Morgan Stanley on Axon Enterprise (AXON): 'we would be buyers of weakness'

Morgan Stanley analyst Meta Marshall reiterated an Overweight rating and $675.00 price target on Axon Enterprise (NASDAQ: AXON)

The analyst commented, "We find the latest moves on AXON to be largely reactionary and perhaps somewhat rotation based. We continue to see meaningful growth opportunities for AXON, particularly as one of the few software names monetizing AI tailwinds today. Buyers of weakness; remain OW... We would be buyers of weakness, as we see $159bn TAM and competitive positioning as attractive. Additionally, valuation is now below that of large cap software on a EV/S/G and P/E/g basis - for a name that has traditionally traded at a premium given scarcity value of profile."

For an analyst ratings summary and ratings history on Axon Enterprise click here. For more ratings news on Axon Enterprise click here.

Shares of Axon Enterprise closed at $372.87 yesterday.

You May Also Be Interested In

• 22nd Century Group files prospectus for warrant share resale
• Independence Realty Trust (IRT) files mixed shelf
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders